These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 33248208)

  • 1. COVID-19-Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group.
    McKinney J; Connelly KA; Dorian P; Fournier A; Goodman JM; Grubic N; Isserow S; Moulson N; Philippon F; Pipe A; Poirier P; Taylor T; Thornton J; Wilkinson M; Johri AM
    Can J Cardiol; 2021 Aug; 37(8):1165-1174. PubMed ID: 33248208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians.
    Wilson MG; Hull JH; Rogers J; Pollock N; Dodd M; Haines J; Harris S; Loosemore M; Malhotra A; Pieles G; Shah A; Taylor L; Vyas A; Haddad FS; Sharma S
    Br J Sports Med; 2020 Oct; 54(19):1157-1161. PubMed ID: 32878870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play.
    Kim JH; Levine BD; Phelan D; Emery MS; Martinez MW; Chung EH; Thompson PD; Baggish AL
    JAMA Cardiol; 2021 Feb; 6(2):219-227. PubMed ID: 33104154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes.
    Raukar NP; Cooper LT
    Sports Health; 2021 Mar; 13(2):145-148. PubMed ID: 33201768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening.
    Martinez MW; Tucker AM; Bloom OJ; Green G; DiFiori JP; Solomon G; Phelan D; Kim JH; Meeuwisse W; Sills AK; Rowe D; Bogoch II; Smith PT; Baggish AL; Putukian M; Engel DJ
    JAMA Cardiol; 2021 Jul; 6(7):745-752. PubMed ID: 33662103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19: An Expert Consensus Statement.
    Phelan D; Kim JH; Elliott MD; Wasfy MM; Cremer P; Johri AM; Emery MS; Sengupta PP; Sharma S; Martinez MW; La Gerche A
    JACC Cardiovasc Imaging; 2020 Dec; 13(12):2635-2652. PubMed ID: 33303102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry.
    Daniels CJ; Rajpal S; Greenshields JT; Rosenthal GL; Chung EH; Terrin M; Jeudy J; Mattson SE; Law IH; Borchers J; Kovacs R; Kovan J; Rifat SF; Albrecht J; Bento AI; Albers L; Bernhardt D; Day C; Hecht S; Hipskind A; Mjaanes J; Olson D; Rooks YL; Somers EC; Tong MS; Wisinski J; Womack J; Esopenko C; Kratochvil CJ; Rink LD;
    JAMA Cardiol; 2021 Sep; 6(9):1078-1087. PubMed ID: 34042947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging.
    Starekova J; Bluemke DA; Bradham WS; Eckhardt LL; Grist TM; Kusmirek JE; Purtell CS; Schiebler ML; Reeder SB
    JAMA Cardiol; 2021 Aug; 6(8):945-950. PubMed ID: 33443537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes.
    Johri AM; Poirier P; Dorian P; Fournier A; Goodman JM; McKinney J; Moulson N; Pipe A; Philippon F; Taylor T; Connelly K; Baggish AL; Krahn A; Sharma S
    Can J Cardiol; 2019 Jan; 35(1):1-11. PubMed ID: 30595170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play.
    Cavigli L; Frascaro F; Turchini F; Mochi N; Sarto P; Bianchi S; Parri A; Carraro N; Valente S; Focardi M; Cameli M; Bonifazi M; D'Ascenzi F
    Int J Cardiol; 2021 Aug; 336():130-136. PubMed ID: 34082008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Troponin Testing as a Component of Return to Play Cardiac Screening in Young Competitive Athletes Following SARS-CoV-2 Infection.
    Moulson N; Petek BJ; Churchill TW; Drezner JA; Harmon KG; Kliethermes SA; Mellacheruvu P; Patel MR; Baggish AL;
    J Am Heart Assoc; 2022 Aug; 11(16):e025369. PubMed ID: 35929475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.
    Moulson N; Petek BJ; Drezner JA; Harmon KG; Kliethermes SA; Patel MR; Baggish AL;
    Circulation; 2021 Jul; 144(4):256-266. PubMed ID: 33866822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term manifestations of COVID-19 in athletes: a narrative review.
    Ribeiro J; Caldeira D; Dores H
    Phys Sportsmed; 2024 Oct; 52(5):452-459. PubMed ID: 38375735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Cardiovascular Society Cardiovascular Screening of Competitive Athletes: The Utility of the Screening Electrocardiogram to Predict Sudden Cardiac Death.
    McKinney J; Johri AM; Poirier P; Fournier A; Goodman JM; Moulson N; Pipe A; Philippon F; Taylor T; Connelly K; Dorian P
    Can J Cardiol; 2019 Nov; 35(11):1557-1566. PubMed ID: 31679625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of the Canadian Cardiovascular Society/Canadian Heart Rhythm Society Cardiovascular Screening and Care of Athletes Program Into Practice.
    Johri AM; Grubic N; Kuljic N; O'Connor M; Graham K; Bennett R; Moulson N
    Can J Cardiol; 2019 Jul; 35(7):935-939. PubMed ID: 31292094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared Decision Making and the Cardiovascular Care of Athletes: Is It Time to Get Back in the Game?
    Moulson N; Dorian P; Krahn A; Virani A; Isserow S; McKinney J
    Can J Cardiol; 2020 Jun; 36(6):941-944. PubMed ID: 32173054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocarditis Screening Methods in Athletes After SARS-CoV-2 Infection - a Systematic Review.
    Hofbauer T; Humann K; Neidenbach RC; Scharhag J
    Int J Sports Med; 2023 Dec; 44(13):929-940. PubMed ID: 37225132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
    Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus recommendations for COVID-19-related myocarditis in athletes: proof of concept-case report.
    Abdelfattah OM; Mathur T; Martinez MW
    Eur Heart J Case Rep; 2023 Feb; 7(2):ytad038. PubMed ID: 36814698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties.
    Eichhorn C; Bière L; Schnell F; Schmied C; Wilhelm M; Kwong RY; Gräni C
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):494-507. PubMed ID: 31202742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.